CN Patent

CN106938982A — 布瑞哌唑的制备方法及用于制备布瑞哌唑的化合物

Assigned to Lianyungang Hao Hai Pharmaceutical Technology Co Ltd · Expires 2017-07-11 · 9y expired

What this patent protects

本发明公开了一种布瑞哌唑的制备方法及用于制备布瑞哌唑的化合物，其中Ⅳ化合物与式Ⅷ化合物反应，以便获得布瑞哌唑。该路线具有原料廉价易得、合成工艺简单、绿色环保、适用于工业化生产等优点。

USPTO Abstract

本发明公开了一种布瑞哌唑的制备方法及用于制备布瑞哌唑的化合物，其中Ⅳ化合物与式Ⅷ化合物反应，以便获得布瑞哌唑。该路线具有原料廉价易得、合成工艺简单、绿色环保、适用于工业化生产等优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN106938982A
Jurisdiction
CN
Classification
—
Expires
2017-07-11
Drug substance claim
No
Drug product claim
No
Assignee
Lianyungang Hao Hai Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.